GCP
BLFS icon

GSA Capital Partners’s BioLife Solutions BLFS Stock Holding History

GSA Capital Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-27,855
Closed -$531K – 1763
2026
Q1 		$531K Buy
+27,855
New +$616K 0.03% 878
2023
Q2 		– Sell
-45,289
Closed -$985K – 1530
2023
Q1 		$985K Buy
+45,289
New +$1.02M 0.1% 320
2019
Q1 		– Sell
-13,800
Closed -$166K – 1434
2018
Q4 		$166K Buy
13,800
+2,400
+21% +$28.7K 0.02% 1144
2018
Q3 		$200K Buy
+11,400
New +$226K 0.01% 1492

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

GSA Capital Partners's BLFS Position: Q2 2026 in Review

GSA Capital Partners sold out of BioLife Solutions (BLFS) in Q2 2026, closing a stake of 27,855 shares — an estimated $531K sold.

GSA Capital Partners first reported a position in BLFS in Q3 2018 and held it in 4 quarters. The position peaked at $985K in Q1 2023. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • GSA Capital Partners reported no remaining BioLife Solutions position as of Q2 2026 after selling out during the quarter.
  • GSA Capital Partners sold 27,855 BioLife Solutions shares in Q2 2026, an estimated $531K.
  • GSA Capital Partners first reported a position in BioLife Solutions in Q3 2018 and held it in 4 quarters.
  • GSA Capital Partners's BioLife Solutions position peaked at $985K in Q1 2023.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on GSA Capital Partners's 13F filing for Q2 2026, filed 6 Aug 2026.